← Back to Clinical Trials
Recruiting NCT06419920

NCT06419920 Prosthetic Performance Enhancement Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06419920
Status Recruiting
Phase
Sponsor University of Nevada, Las Vegas
Condition Amputation
Study Type INTERVENTIONAL
Enrollment 35 participants
Start Date 2025-06-26
Primary Completion 2026-11

Trial Parameters

Condition Amputation
Sponsor University of Nevada, Las Vegas
Study Type INTERVENTIONAL
Phase N/A
Enrollment 35
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-06-26
Completion 2026-11
Interventions
Flat terrain locomotor trainingUneven terrain locomotor training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this research is to determine the feasibility of an uneven terrain walking program for lower limb prosthesis users. The training is designed to induce step-to-step variability during walking within a safe environment, with the aim of improving walking skill and confidence.

Eligibility Criteria

Inclusion Criteria: * lower limb amputation at ankle (Symes) level and above * age 18+ years * fitted with a walking prosthesis and use it regularly for home and/or community ambulation * good socket fit, assessed by a score of 8-10 on the socket fit comfort scale * able to walk for three minutes at a time with or without an assistive device Exclusion Criteria: * leg/foot ulcer or other conditions that cause pain during weight-bearing * poor skin integrity that could cause tissue breakdown by walking * cardiovascular, respiratory or other critical health conditions that preclude moderate physical activity * unilateral or bilateral upper limb absence or loss at the wrist and above that precludes use of handrails bilaterally, or would require asymmetrical adaptation to body posture for use. * pregnancy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology